Loci Related to Metabolic-Syndrome Pathways Including LEPR,HNF1A, IL6R, and GCKR Associate with Plasma C-Reactive Protein: The Women's Genome Health Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PLINK: a tool set for whole-genome association and population-based linkage analyses.
Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/519795 · Cited by 34,089 · cited 4×
“For all genotype-phenotype association analyses, we assumed an additive model of inheritance and initially conducted univariate linear-regression analyses to test the null hypothesis that adjusted log CRP levels did not differ by individual SNP genotypes.(12) To conservatively identify loci that might be associated wi…”
BackgroundMethodInfluentialRidker, P. M., Hennekens, C. H., Buring, J. E., & Rifai, N. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003233421202 · Cited by 5,850 · cited 1×
“such as IL-6, which have previously been shown in this cohort to correlate positively with CRP levels and to independently predict risk of future vascular events and diabetes.(21) In this regard, our finding in the full cohort that polymorphism in the IL6R gene is an additional determinant of CRP expression is consist…”
ResultSelf-citationInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Self-citationC-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
Pradhan, A. D. (2001) · JAMA · doi:10.1001/jama.286.3.327 · Cited by 4,433
Ridker, P. M., Rifai, N., Rose, L., Buring, J. E., & Cook, N. R. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021993 · Cited by 3,604
Self-citationGenome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young
Fajans, S. S., Bell, G. I., & Polonsky, K. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmra002168 · Cited by 1,123 · cited 2×
“In this light, it is also of interest that a second loci described here as a genetic determinant of CRP, hepatic transcription factor-1 that codes for hepatic nuclear factor 1-alpha, is known to be functionally linked to a different type of MODY (MODY-3, MIM 606391), a form of noninsulin-dependent diabetes with an aut…”
BackgroundThe Fine-Scale Structure of Recombination Rate Variation in the Human Genome
McVean, G. A. T., Myers, S. R., Hunt, S., Deloukas, P., Bentley, D. R., & Donnelly, P. (2004) · Science · doi:10.1126/science.1092500 · Cited by 987
Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. (2001) · Circulation · doi:10.1161/hc5001.101061 · Cited by 825
Association of apolipoprotein E genotypes with lipid levels and coronary risk
Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., Keavney, B., Collins, R., Wiman, B., de Faire, U., et al. (2007) · JAMA · doi:10.1001/jama.298.11.1300 · Cited by 794
Targeting C-reactive protein for the treatment of cardiovascular disease.
Pepys, M. B., Hirschfield, G. M., Tennent, G. A., Ruth Gallimore, J., Kahan, M. C., Bellotti, V., Hawkins, P. N., Myers, R. M., Smith, M. D., Polara, A., et al. (2006) · Nature · doi:10.1038/nature04672 · Cited by 672 · cited 1×
“Moreover, direct CRP inhibitors with apparent vascular-protective effects have recently been described.(31) However, it remains controversial as to whether CRP itself is a target for therapy, and other data (albeit with limited power to define an informative null result) have not linked CRP polymorphism to incident ev…”
BackgroundHan, T. S., Sattar, N., Williams, K., Gonzalez-Villalpando, C., Lean, M. E. J., & Haffner, S. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2016 · Cited by 513
Apolipoprotein-mediated pathways of lipid antigen presentation
Elzen, P. V. D., Garg, S., León, L., Brigl, M., Leadbetter, E. A., Gumperz, J. E., Dascher, C. C., Cheng, T.-Y., Sacks, F. M., Illarionov, P. A., et al. (2005) · Nature · doi:10.1038/nature04001 · Cited by 380
Comparison of Fine-Scale Recombination Rates in Humans and Chimpanzees
Winckler, W., Myers, S. R., Richter, D. J., Onofrio, R. C., McDonald, G. J., Bontrop, R. E., McVean, G. A. T., Gabriel, S. B., Reich, D., Donnelly, P., et al. (2005) · Science · doi:10.1126/science.1105322 · Cited by 356
Induction of leptin resistance through direct interaction of C-reactive protein with leptin
Chen, K., Li, F., Li, J., Cai, H., Strom, S., Bisello, A., Kelley, D. E., Friedman-Einat, M., Skibinski, G. A., McCrory, M. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1372 · Cited by 325
Carlson, C. S., Aldred, S. F., Lee, P. K., Tracy, R. P., Schwartz, S. M., Rieder, M., Liu, K., Williams, O. D., Iribarren, C., Lewis, E. C., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/431366 · Cited by 324
C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men
Laaksonen, D. E., Niskanen, L., Nyyss�nen, K., Punnonen, K., Tuomainen, T.-P., Valkonen, V.-P., Salonen, R., & Salonen, J. T. (2004) · Diabetologia · doi:10.1007/s00125-004-1472-x · Cited by 289
Lange, L. A., Carlson, C. S., Hindorff, L. A., Lange, E. M., Walston, J., Durda, J. P., Cushman, M., Bis, J. C., Zeng, D., Lin, D., et al. (2006) · JAMA · doi:10.1001/jama.296.22.2703 · Cited by 266 · cited 1×
“Recent work has identified polymorphisms within the CRP gene that associate with circulating CRP levels and with incident vascular events, data that support a potential causal role for CRP itself.(30) Moreover, direct CRP inhibitors with apparent vascular-protective effects have recently been described.”
BackgroundHage, F. G., & Szalai, A. J. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.012 · Cited by 241
Kathiresan, S., Larson, M. G., Vasan, R. S., Guo, C.-Y., Gona, P., Keaney, J. F., Wilson, P. W. F., Newton-Cheh, C., Musone, S. L., Camargo, A. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.591271 · Cited by 231
Association of Common CRP Gene Variants with CRP Levels and Cardiovascular Events
Miller, D. T., Zee, R. Y. L., Suk Danik, J., Kozlowski, P., Chasman, D. I., Lazarus, R., Cook, N. R., Ridker, P. M., & Kwiatkowski, D. J. (2005) · Annals of Human Genetics · doi:10.1111/j.1529-8817.2005.00210.x · Cited by 220
Self-citationSparsø, T., Andersen, G., Nielsen, T., Burgdorf, K. S., Gjesing, A. P., Nielsen, A. L., Albrechtsen, A., Rasmussen, S. S., Jørgensen, T., Borch-Johnsen, K., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0865-z · Cited by 171
Ridker, P. M., Chasman, D. I., Zee, R. Y. L., Parker, A., Rose, L., Cook, N. R., Buring, J. E., & for the Women’s Genome Health Study Working Group (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.099366 · Cited by 171
Self-citationAdmixture Mapping of an Allele Affecting Interleukin 6 Soluble Receptor and Interleukin 6 Levels
Reich, D., Patterson, N., Ramesh, V., De Jager, P. L., McDonald, G. J., Tandon, A., Choy, E., Hu, D., Tamraz, B., Pawlikowska, L., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/513206 · Cited by 169
Crawford, D. C., Sanders, C., Qin, X., Smith, J. D., Shephard, C., Wong, M., Witrak, L., Rieder, M. J., & Nickerson, D. A. (2006) · Circulation · doi:10.1161/circulationaha.106.615740 · Cited by 162
Kado, S., Nagase, T., & Nagata, N. (1999) · Acta Diabetologica · doi:10.1007/s005920050147 · Cited by 158
Toniatti, C., Demartis, A., Monaci, P., Nicosia, A., & Ciliberto, G. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07897.x · Cited by 139
Chasman, D. I., Kozłowski, P., Zee, R. Y. L., Kwiatkowski, D. J., & Ridker, P. M. (2006) · Genes and Immunity · doi:10.1038/sj.gene.6364289 · Cited by 70
Self-citationJudson, R., Brain, C. W., Dain, B., Windemuth, A., Ruaño, G., & Reed, C. R. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.07.012 · Cited by 67
García‐Herrero, C. M., Galán, M., Vincent, O., Flández, B., Gargallo, M., Delgado, E., Blázquez, E., & Navas, M. (2006) · Diabetologia · doi:10.1007/s00125-006-0542-7 · Cited by 67
Austin, M. A., Zhang, C., Humphries, S. E., Chandler, W. L., Talmud, P. J., Edwards, K. L., Leonetti, D. L., McNeely, M. J., & Fujimoto, W. Y. (2004) · Annals of Human Genetics · doi:10.1046/j.1529-8817.2004.00078.x · Cited by 62
Apolipoprotein E polymorphism – a risk factor for metabolic syndrome
Sima, A. V., Iordan, A., & Stancu, C. S. (2007) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2007.258 · Cited by 61
Zhang, Y.-Y., Gottardo, L., Mlynarski, W. M., Frazier, W. T., Nolan, D. A., Duffy, J. E., Marescotti, M. C., Gervino, E. V., Johnstone, M. T., Mantzoros, C. S., et al. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.043 · Cited by 42
Cited by
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
“(65) The functional genomic work required to unravel the biological pathways revealed by GWAS will require considerable investigative effort in years to come.”
BackgroundSelf-citationBenefits and limitations of genome-wide association studies
Tam, V., Patel, N., Turcotte, M., Bossé, Y., Paré, G., & Meyre, D. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0127-1 · Cited by 2,092
Pierce, B. L., Ahsan, H., & VanderWeele, T. J. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyq151 · Cited by 1,836
Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
Genetic Mapping in Human Disease
Altshuler, D., Daly, M. J., & Lander, E. S. (2008) · Science · doi:10.1126/science.1156409 · Cited by 1,452
Metadata
- Authors
- Ridker, P. M., Pare, G., Parker, A., Zee, R. Y. L., Danik, J. S., Buring, J. E., Kwiatkowski, D., Cook, N. R., Miletich, J. P., & Chasman, D. I.
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 82
- Issue
- 5
- Pages
- 1185-1192
- ISSN
- 0002-9297 (ISSN-L)
- OpenAlex
- W2007272726
- Cited by
- 343
- References
- 33
- FWCI
- 21.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.